Clinical implications of a possible role of vitamin D in multiple sclerosis

Journal of Neurology

Volumn 256, Issue 9, 2009, Pages 1468-1479

  Pierrot Deseilligny, Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Multiple sclerosis; Vitamin D

Indexed keywords

COLECALCIFEROL; VITAMIN D;

ALLERGIC ENCEPHALOMYELITIS; ENVIRONMENTAL FACTOR; EXPERIMENTAL STUDY; HUMAN; IMMUNOMODULATION; LIGHT EXPOSURE; MULTIPLE SCLEROSIS; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; GEOGRAPHY; HUMANS; MULTIPLE SCLEROSIS; PREVALENCE; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 69549114460     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5139-x     Document Type: Review

References (135)

1. EP Abad M Pérez T Alarcon E Castro F Diaz R Santibanez 2008 Epidemiological evidence of multiple sclerosis in Ecuador Mult Scler 14 Suppl 1 S55 S56
2. ED Acheson CA Bachrach FM Wright 1960 Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables Acta Psychiatr Scand Suppl 35 37 42 10.1111/j.1600-0447.1960.tb08674. x
3. A Alonso MA Hernan 2008 Temporal trends in the incidence of multiple sclerosis: a systematic review Neurology 7 129 135 10.1212/01.wnl.0000316802. 35974.34
4. R Andersen C Molgaard LT Skovgaard C Brot KD Cashman E Chabros, et al. 2005 Teenage girls and elderly women living in northern Europe have low winter vitamin D status Eur J Clin Nutr 59 533 541 10.1038/sj.ejcn.1602108 (Pubitemid 40528667)
5. A Ascherio KL Munger 2007 Environmental risk factors for multiple sclerosis. Part I: the role of infection Ann Neurol 61 288 299 10.1002/ana.21117 (Pubitemid 46676728)
6. A Ascherio KL Munger 2007 Environmental risk factors for multiple sclerosis. Part II: non-infectious factors Ann Neurol 61 504 513 10.1002/ana.21141 (Pubitemid 47068132)
7. A Ascherio K Munger 2008 Epidemiology of multiple sclerosis: from risk factors to prevention Semin Neurol 28 17 28 10.1055/s-2007-1019126 (Pubitemid 351273081)
8. M Barnes MP Bonham PJ Robson JJ Strain AS Lowe-Strong J Eaton-Evans, et al. 2007 Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers Mult Scler 13 670 672 10.1177/1352458506072666 (Pubitemid 46939536)
9. BR Becklund DW Hansen HF Deluca 2009 Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin Proc Natl Acad Sci USA 106 13 5276 5281
10. HA Bischoff-Ferrari E Giovannucci WC Willett T Dietrich B Dawson-Hughes 2006 Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am J Clin Nutr 84 18 28
11. DD Branisteanu M Waer S Sobis S Marcelis M Vandeputte R Bouillon 1995 Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3 J Neuroimmunol 61 151 160 10.1016/0165-5728(95)00076-E
12. SJ Brown 2006 The role of vitamin D in multiple sclerosis Ann Pharmacother 40 1158 1161 10.1345/aph.1G513 (Pubitemid 43886975)
13. JM Burton S Kimball R Vieth A Bar-Or HM Dosch L Thibault, et al. 2008 A phase I/II dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis Mult Scler 14 Suppl 1 S34
14. MT Cantorna 2006 Vitamin D and its role in immunology: multiple sclerosis and inflammatory bowel disease Prog Biophys Mol Biol 92 60 64 10.1016/j.pbiomolbio.2006.02.020 (Pubitemid 43831951)
15. MT Cantorna 2008 Vitamin D and multiple sclerosis: an update Nutr Rev 66 10 Suppl S135 S138
16. MT Cantorna BD Mahon 2004 Mounting evidence for vitamin D as an environmental factor affecting autoimmune prevalence Exp Biol Med 229 1136 1142
17. MT Cantorna CE Hayes HF DeLuca 1996 1,25-dihydroxyvitamin D3 reversibly blocks the progression of encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci USA 93 7861 7864 10.1073/pnas.93.15.7861 (Pubitemid 26277129)
18. MT Cantorna WD Woodward CE Hayes HF DeLuca 1998 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4 J Immunol 160 5314 5319
19. MT Cantorna J Humpal-Winter HF DeLuca 1999 Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice J Nutr 129 1966 1971
20. E Cavalier P Denanaye JP Chapelle JC Souberbielle 2009 Vitamin D: current status and perspectives Clin Chem Lab Med 47 120 127 10.1515/CCLM.2009.036
21. LO Chailurkit R Rajatanavin B Teerarungsikul B Ongphiphadhanakul G Puavilai 1996 Serum vitamin D, parathyroid hormone and biochemical markers of bone turnover in normal Thai subjects J Med Assoc Thai 79 499 504
22. MC Chapuy P Preziosi M Maamer S Arnaud P Galan S Hercberg PJ Meunier 1996 Prevalence of vitamin D insufficiency in an adult normal population Osteoporos Int 7 439 443 10.1007/s001980050030
23. A Chaudhuri 2005 Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis Med Hypotheses 64 608 618 10.1016/j.mehy.2004.06.022 (Pubitemid 40023030)
24. Correale J, Ysrraelit MC, Gaitan MI (2009) Immunomodulatory effects of 1,25-dihydroxyvitamin D3 in multiple sclerosis. Brain [Epub ahead of print]
25. B Dawson-Hughes RP Heaney MF Holick P Lips PJ Meunier R Vieth 2006 Estimates of optimal vitamin D status Osteoporos Int 16 713 716 10.1007/s00198-005-1867-7
26. T Dwyer I van der Mei AL Ponsonby BV Taylor J Stankovich JD McKay, et al. 2008 Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis Neurology 7 583 589 10.1212/01.wnl.0000323928.57408. 93
27. M Elian G Dean 1987 Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies J Neurol Neurosurg Psychiatry 50 327 332 10.1136/jnnp.50.3.327
28. M Elian G Dean 1993 Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean and East and West Africa J Neurol Neurosurg Psychiatry 56 454 457 10.1136/jnnp.56.5.454 (Pubitemid 23171771)
29. M Elian S Nightingale G Dean 1990 Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies J Neurol Neurosurg Psychiatry 53 906 911 10.1136/jnnp.53.10.906
30. A Fromont J Adnet L Clerc C Bonithon Kopp C Binquet T Moreau 2008 The French prevalence gradient of multiple sclerosis according to gender Mult Scler 14 Suppl 1 S65
31. CR Gale CN Martyn 1995 Migrant studies in multiple sclerosis Prog Neurobiol 47 425 448 10.1016/0301-0082(95)00033-X (Pubitemid 26022928)
32. E Garcion L Sindji S Nataf P Brachet F Darcy CN Montero-Menei 2003 Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-hydroxyvitamin D3 leads to early effects within the central nervous system Acta Neuropathol 105 438 448
33. AA Ginde MC Liu CA Camargo Jr 2009 Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004 Arch Intern Med 169 626 632 10.1001/archinternmed.2008.604
34. G Giovannoni G Ebers 2007 Multiple sclerosis: the environment and causation Curr Opin Neurol 20 261 268 10.1097/WCO.0b013e32815610c2 (Pubitemid 46743106)
35. P Goldberg 1974 Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part I: sunlight, dietary factors and epidemiology Int J Environ Stud 6 19 27 10.1080/ 00207237408709630
36. P Goldberg MC Fleming EH Picard 1986 Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D Med Hypotheses 21 193 200 10.1016/0306-9877(86)90010-1 (Pubitemid 17201931)
37. DS Goodin 2009 The causal cascade to multiple sclerosis: a model for pathogenesis PLoS One 4 e4565 10.1371/journal.pone.0004565
38. WB Grant MF Holick 2005 Benefits and requirements of vitamin D for optimal health: a review Altern Med Rev 10 94 111
39. Grant WB, Cross HS, Garland CF, Gohram ED, Moan J, Peterlik L et al (2009) Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol [Epub ahead of print]
40. T Hagenau R Vest TN Gissel CS Poulsen M Erlandsen L Mosekilde, et al. 2009 Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis Osteoporos Int 20 133 140 10.1007/s00198-008-0626-y
41. SR Hammond DR English JG McLeod 2000 The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia Brain 123 968 974 10.1093/brain/123.5.968
42. HE Hanwell R Vieth A Bar-Or S Sadovnick D Arnold B Banwell, et al. 2008 Serum 25-hydroxyvitamin D status as a determinant of multiple sclerosis following an initial demyelinating event in children Mult Scler 14 Suppl 1 S6 10.1177/1352458507079657 (Pubitemid 351541393)
43. JN Hathcock A Shao R Vieth R Heaney 2007 Risk assessment for vitamin D Am J Clin Nutr 85 6 18
44. CH Hawks 2005 Are multiple sclerosis patients risk-takers? QJM 98 895 911 10.1093/qjmed/hci135 (Pubitemid 43071456)
45. CE Hayes MT Cantorna HF De Luca 1997 Vitamin D and multiple sclerosis Proc Soc Biol Med 216 21 27
46. CE Hayes E Donald Acheson 2008 A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10 Med Hypotheses 71 85 90 10.1016/j.mehy.2008.01.031
47. RP Heaney KM Davies TC Chen MF Holick J Bager-Lux 2003 Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Am J Clin Nutr 77 204 210
48. MF Holick 2004 Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am J Clin Nutr 80 6 suppl 1678S 1688S
49. MF Holick 2005 The vitamin D epidemic and its health consequences J Nutr 135 2739S 2748S
50. MF Holick 2008 Vitamin D: a D-lightful health perspective Nutr Rev 66 10 Suppl 2 S182 S194 10.1111/j.1753-4887.2008.00104.x
51. MF Holick 2008 The vitamin D deficiency pandemic and consequences for non-skeletal health: mechanisms of action Mol Aspects Med 29 361 368 10.1016/j.mam.2008.08.008
52. BW Hollis 2005 Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D J Nutr 135 317 322
53. T Holmoy 2008 Vitamin D status modulates the immune response to Epstein-Barr virus: synergistic effect of risk factors in multiple sclerosis Med Hypotheses 70 66 69 10.1016/j.mehy.2007.04.030 (Pubitemid 350167496)
54. T Holmoy AL Hestvik 2008 Multiple sclerosis: immunopathogenesis and controversies in defining the cause Curr Opin Infect Dis 21 271 278 10.1097/QCO.0b013e3282f88b48 (Pubitemid 351634399)
55. E Hyppönen C Power 2007 Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors Am J Clin Nutr 85 860 868
56. International Multiple Sclerosis Genetics Consortium (2008) The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 10(1):11-14
57. T Islam WJ Gauderman W Cozen TM Mack 2007 Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins Neurology 69 381 388 10.1212/01.wnl.0000268266.50850.48 (Pubitemid 47205666)
58. MT Kampman M Brustad 2008 Vitamin D: a candidate for the environmental effect in multiple sclerosis-observations from Norway Neuroepidemiology 30 140 146 10.1159/000122330 (Pubitemid 351667793)
59. MT Kampman T Wilsgaard SI Mellgren 2007 Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle J Neurol 254 471 477 10.1007/s00415-006-0395-5 (Pubitemid 46786722)
60. O Kantarci O Wingerchuk 2006 Epidemiology and natural history of multiple sclerosis: new insights Curr Opin Neurol 19 248 254 10.1097/01.wco.0000227033. 47458.82 (Pubitemid 43804678)
61. SM Kimball MR Ursell P O'Connor R Vieth 2007 Safety of vitamin D3 in adults with multiple sclerosis Am J Clin Nutr 86 645 651
62. MG Kimlin 2008 Geographic location of vitamin D synthesis Mol Aspects Med 29 453 461 10.1016/j.mam.2008.08.005
63. J Kragt B van Amerogen J Killestein CD Dijkstra BMJ Vitdehaag CH Polman, et al. 2009 Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women Mult Scler 15 9 15 10.1177/1352458508095920
64. JF Kurtzke 1967 On the fine structure of the distribution of multiple sclerosis Acta Neurol Scand 43 257 282 10.1111/j.1600-0404.1967.tb05733.x
65. JF Kurtzke 1995 MS epidemiology world wide. One view of current status Acta Neurol Scand 161 Suppl 23 33 10.1111/j.1600-0404.1995.tb05853.x
66. JF Kurtzke JW Beebe JE Norman 1985 Epidemiology of multiple sclerosis in US veterans: III; Migration and the risk of MS Neurology 35 672 678
67. JM Lemire DC Archer 1991 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 1103 1107 10.1172/JCI115072
68. ER Linhares DA Jones JM Round RH Edwards 1984 Effect of nutrition on vitamin D status: studies on healthy and poorly nourished Brazilian children Am J Clin Nutr 39 625 630
69. P Lips 2006 Vitamin D physiology Prog Biophys Mol Biol 92 4 8 10.1016/j.pbiomolbio.2006.02.016 (Pubitemid 43831956)
70. P Lips 2007 Vitamin D status and nutrition in Europe and Asia J Steroid Biochem Mol Biol 103 620 625 10.1016/j.jsbmb.2006.12.076 (Pubitemid 46401309)
71. AC Looker CM Pfeiffer DA Lacher RL Schleicher MF Picciano EA Yetley 2008 Serum 25-dihydroxyvitamin D status in the US population: 1988-1994 compared with 2000-2004 Am J Clin Nutr 88 1519 1527 10.3945/ajcn.2008.26182
72. R Lucas BV Taylor A-L Ponsonby P Chapman A Coulthard K Dear, et al. 2008 Latitudinal variation in incidence of first demyelinating events: descriptive analyses of case participants in the Ausimmune Study Mult Scler 14 Suppl 1 S190 S191
73. BD Mahon SA Gordon J Cruz F Cosman MT Cantorna 2003 Cytokine profile in patients with multiple sclerosis following vitamin D supplementation J Neuroimmunol 134 128 132 10.1016/S0165-5728(02)00396-X (Pubitemid 36050838)
74. N Makhani S Magalaes C Fairbrother B Banwell 2008 Vitamin D status in children with multiple sclerosis Mult Scler 14 Suppl 1 S191
75. G Mamutse J Woolmore E Pye J Partridge M Boggild C Young, et al. 2008 Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis Mult Scler 14 1280 1283 10.1177/1352458508094643
76. BL Mark JA Carson 2006 Vitamin D and autoimmune disease-implications for practice from multiple sclerosis literature J Am Diet Assoc 106 418 424 10.1016/j.jada.2005.12.009 (Pubitemid 43288019)
77. FS Mattner S Smiroldo F Gabliati M Muller P Di Lucia PL Poliani, et al. 2000 Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3 Eur J Neuroimmunol 30 498 508 10.1002/1521-4141(200002) 30:2<498::AID-IMMU498>3.0.CO;2-Q (Pubitemid 30098842)
78. F Meehan HF DeLuca 2002 The vitamin D receptor is essential for 1alpha, 25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice Arch Biochem Biophys 408 200 204 10.1016/S0003-9861(02)00580-5 (Pubitemid 36027040)
79. F Meehan HF DeLuca 2002 CD8+ T cells are not necessary for 1α, 25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis Proc Natl Acad Sci USA 99 5557 5560
80. KL Munger SM Zhang E O'Reilly MA Hernan MJ Olek WC Willet A Ascherio 2004 Vitamin D intake and incidence of multiple sclerosis Neurology 62 60 65
81. KL Munger LI Levin BW Hollis NS Howard A Ascherio 2006 Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2832 2838 10.1001/jama.296.23.2832 (Pubitemid 44969183)
82. G Muthian HP Raikvar J Rajasingh JJ Brigh 2006 1,25-dihydroxyvitamin D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis J Neurosci Res 83 1299 1309 10.1002/jnr.20826 (Pubitemid 43668013)
83. M Namaka A Crook A Doupe K Kler M Vasconcelos M Klowak, et al. 2008 Examining the evidence: complementary adjunctive therapies for multiple sclerosis Neurol Res 30 710 719 10.1179/174313208X325038
84. FE Nashold DJ Miller DE Hayes 2000 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation of mice with experimental autoimmune encephalomyelitis J Neuroimmunol 103 171 179 10.1016/S0165-5728(99)00247-7 (Pubitemid 30079729)
85. FE Nashold KA Hoag J Goverman CE Hayes 2001 Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis J Neuroimmunol 119 16 29 10.1016/S0165-5728(01)00360-5 (Pubitemid 32781724)
86. S Nataf E Garcio F Darcy D Chabannes JY Muller P Brachet, et al. 1996 1,25-dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis J Neuropathol Exp Neurol 55 904 914
87. J Nieves F Cosman J Herbert V Shen R Lindsay 1994 High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis Neurology 44 1687 1692
88. M Niino T Fukazawa S Kikuchi H Sasaki 2008 Therapeutic potential of vitamin D for multiple sclerosis Curr Med Chem 15 499 505 10.2174/ 092986708783503159
89. SM Orton AP Morris BM Herrera SV Ramagopalan MR Lincoln MJ Chao, et al. 2008 Evidence for genetic regulation of vitamin D status in twins in multiple sclerosis Am J Clin Nutr 88 441 447
90. LB Pedersen FE Nashold KM Spach CE Hayes 2007 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokines synthesis and monocyte trafficking J Neurosci Res 85 2480 2490 10.1002/jnr.21382 (Pubitemid 47204762)
91. M Pugliatti G Rosati H Carton T Riise J Drulovic L Vécsei I Milanov 2006 The epidemiology of multiple sclerosis in Europe Eur J Neurol 13 700 722 10.1111/j.1468-1331.2006.01342.x (Pubitemid 44143944)
92. M Pugliatti HF Harbo T Holmoy MT Kampman KM Myhr T Riise T Wolfson 2008 Environmental risk factors in multiple sclerosis Acta Neurol Scand Suppl 188 34 40 10.1111/j.1600-0404.2008.01029.x (Pubitemid 351595271)
93. A Raghuwanshi SS Joshi S Christakos 2008 Vitamin D and multiple sclerosis J Cell Biochem 105 338 343 10.1002/jcb.21858
94. Ramagopalan SG, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA et al (2009) Expression of multiple sclerosis-associated MHC class II Allele HLA-DBR1*1501 is regulated by vitamin D. PLoS Genet 5:e1000369. doi: 10.1371/journal.pgen.1000369
95. JE Rockell CM Skeaff SM Williams TJ Green 2006 Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older Osteoporos Int 17 1382 1389 10.1007/s00198-006-0118-x (Pubitemid 44127325)
96. C Roux HA Bischoff-Ferrari SE Papapoulos AE de Papp JA West R Bouillon 2008 New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion Curr Med Res Opin 24 1363 1370 10.1185/030079908X301857 (Pubitemid 351741568)
97. W Royal Y Mia H Li 2008 Vitamins D and A levels and regularity T cells in patients with multiple sclerosis Mult Scler 14 Suppl 1 S242
98. D Rucker JA Allan GH Fick DA Hanley 2002 Vitamin D insufficiency in a population of healthy western Canadians CMAJ 166 1517 1524
99. S Sawcer A Compston 2006 Multiple sclerosis: light at the end of the tunnel Eur J Hum Genet 14 257 258 10.1038/sj.ejhg.5201561
100. RD Simmons AL Ponsonby IA van der Mei P Sheridan 2004 What affects your MS? Responses to an anonymous Internet-based epidemiological study Mult Scler 10 202 211 10.1191/1352458504ms1006oa (Pubitemid 38499915)
101. JS Sloka WE Pryse-Phillips M Stefanelli 2008 The relation of ultraviolet radiation and multiple sclerosis in Newfoundland Can J Neurol Sci 35 69 74
102. J Smolders J Damoiseaux P Menheere R Hupperts 2008 Vitamin D as an immune modulator in multiple sclerosis, a review J Neuroimmunol 194 7 17 10.1016/j.jneuroim.2007.11.014
103. J Smolders P Menheere A Kessels J Damoiseaux R Hupperts 2008 Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis Mult Scler 14 1220 1224 10.1177/1352458508094399
104. J Smolders J Damoiseaux P Menheere JW Trevaert R Hupperts 2009 Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis J Neuroimmunol 207 1-2 117 121
105. M Soilu-Hänninen L Airas I Monnonen A Heikkilä N Viljanen A Hänninen 2005 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis Mult Scler 11 266 271 10.1191/1352458505ms1157oa (Pubitemid 40775180)
106. M Soilu-Hänninen M Laaksonen I Laitinen J-P Erälinna E-M Lillius I Mononen 2008 A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis J Neurol Neurosurg Psychiatry 79 152 157 10.1136/jnnp.2006.105320 (Pubitemid 351236545)
107. JC Souberbielle D Prié M Courbebaisse G Friedlander P Houillier G Maruani, et al. 2008 Actualité sur les effets de la vitamine D et l'évaluation du statut vitaminique D Ann Endocrinol (Paris) 69 501 510 10.1016/j.ando.2008.07.010
108. KM Spach CE Hayes 2005 Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice J Immunol 175 4119 4126
109. KM Spach LB Pedersen FE Nashold T Kayo BS Yandell TA Prolla CE Hayes 2004 Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis Physiol Genomics 18 141 151 10.1152/physiolgenomics.00003.2004 (Pubitemid 39319496)
110. KM Spach FE Nashold BN Dittel CE Hayes 2006 IL-10 signalling is essential for 1,25-dihydroxyvitamin d3-mediated inhibition of experimental autoimmune encephalomyelitis J Immunol 177 6030 6037
111. L Tajouri M Ovcaric R Curtain MP Johnson LR Griffiths P Csurhes, et al. 2005 Variation in vitamin D receptor gene is associated with multiple sclerosis in an Australian population J Neurogenet 19 25 38 10.1080/01677060590949692 (Pubitemid 41656874)
112. BV Taylor A Richardson DF Mason E Wlloughby D Abenethy C Sabel 2008 Prevalence of multiple sclerosis in New Zealand Mult Scler 14 Suppl 1 S202
113. L Tjellesen C Christiansen L Hummer NE Larsen 1983 Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle Acta Endocrinol (Copenh) 102 476 480
114. H Tremlett IA van der Mei F Pittas L Blizzard G Paley D Mesaros, et al. 2008 Monthly ambient sunlight, infections and relapse rates in multiple sclerosis Neuroepidemiology 3 271 279 10.1159/000166602
115. VV Välimäki H Alfthan E Lehmuskallio E Löyttyniemi K Petterson UH Stenman, et al. 2004 Vitamin D status as a determinant of peak bone mass in young Finnish men J Clin Endocrinol Metab 89 76 80 10.1210/jc.2003- 030817 (Pubitemid 38183862)
116. BM VanAmerogen CD Dijkstra P Lips CH Polman 2004 Multiple sclerosis and vitamin D: an update Eur J Nutr 58 1095 1109 10.1038/sj.ejcn.1601952 (Pubitemid 39172383)
117. IA Van der Mei AL Ponsonby L Blizzard T Dwyer 2001 Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation Neuroepidemiology 20 168 174 10.1159/000054783 (Pubitemid 32718873)
118. IAF Van der Mei AL Ponsonby T Dwyer L Blizzard R Simmons BV Taylor, et al. 2003 Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study BMJ 327 1 6 10.1136/bmj.327.7410.316
119. IA Van der Mei AL Ponsonby O Engelsen JA Pasco JJ McGrath DW Eyles, et al. 2007 The high prevalence of vitamin D insufficiency across Australian population is only partly explained by season and latitude Environ Health Perspect 115 1132 1139
120. IA Van der Mei AL Ponsonby T Dwyer L Blizzard BV Taylor T Kilpatrick, et al. 2007 Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia J Neurol 254 581 590 10.1007/s00415-006-0315-8 (Pubitemid 46781963)
121. E Van Etten DD Branisteanu L Overberg R Bouillon A Verstuyf C Mathieu, et al. 2003 Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone Bone 32 397 404 10.1016/S8756-3282(03)00030-9 (Pubitemid 36407540)
122. E Van Etten C Gysemans DD Branisteanu A Verstuyf R Bouillon L Overbergh C Mathieu 2007 Novel insights in the immune function of the vitamin D system: synergism with interferon-beta J Steroid Biochem Mol Biol 103 546 551 10.1016/j.jsbmb.2006.12.094 (Pubitemid 46401359)
123. HJ Van Hoof MJ van der Mooren LM Swinkels CJ Sweep JM Merkus TJ Benraad 1999 Female sex hormone therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study Clin Endocrinol (Oxf) 50 511 516 10.1046/j.1365-2265. 1999.00693.x (Pubitemid 29193236)
124. R Vieth 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am J Clin Nutr 69 842 849
125. R Vieth 2005 The role of vitamin D in the prevention of osteoporosis Ann Med 37 278 285 10.1080/07853890510007313 (Pubitemid 40911065)
126. R Vieth 2006 What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92 26 32 10.1016/j.pbiomolbio.2006.02.003 (Pubitemid 43842065)
127. R Vieth 2007 Vitamin D toxicity, policy, and science J Bone Miner Res 22 Suppl 2 V64 V68 10.1359/jbmr.07s221 (Pubitemid 351304652)
128. R Vieth H Bischoff-Ferrari BJ Boucher B Dawson-Hughes CF Garland RP Heaney, et al. 2007 The urgent need to recommend an intake of vitamin D that is effective Am J Clin Nutr 85 649 650
129. S Vukusic V Van Bokstael S Gosselin C Confavreux 2003 Regional variations of multiple sclerosis prevalence in French farmers J Neurol Neurosurg Psychiatry 78 707 709 10.1136/jnnp.2006.101196
130. CL Wagner SN Taylor BW Hollis 2008 Does vitamin D make the world go 'round'? Breastfeed Med 3 239 250 10.1089/bfm.2008.9984
131. DM Wingerchuck J Lesaux JP Rice M Kremenchtzky GC Ebers 2005 A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis J Neurol Neurosurg Psychiatry 76 1294 1296 10.1136/jnnp.2004.056499 (Pubitemid 41208389)
132. EA Yetley 2008 Assessing the vitamin D status in the US population Am J Clin Nutr 88 558S 5564S
133. Zadshir A, Tareen N, Pan D, Norris K, Martins D (2005) The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 15:S5 97-101
134. JE Zerwekh 2008 Blood biomarkers on vitamin D status Am J Clin Nutr 87 1087S 1091S
135. A Zittermann 2003 Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89 552 572 10.1079/BJN2003837 (Pubitemid 36592083)